Epilepsy Trials in Rochester, United States
Conditions / Epilepsy / Rochester, United States
Epilepsy is a medical condition with active clinical research programs worldwide.
59 total trials for this combination
Showing top 10 of 59 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00113815 | Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures | COMPLETED | PHASE3 |
| NCT00150800 | This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment | COMPLETED | PHASE3 |
| NCT01999777 | Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU | COMPLETED | PHASE3 |
| NCT03478982 | Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern | COMPLETED | PHASE2 |
| NCT00319501 | Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. | COMPLETED | PHASE3 |
| NCT00910247 | Eslicarbazepine Acetate Monotherapy Long Term Study | COMPLETED | PHASE3 |
| NCT00464269 | Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures | COMPLETED | PHASE3 |
| NCT06038929 | Effect of Vagal Nerve Stimulation on Gastric Motor Functions | RECRUITING | NA |
| NCT00334958 | Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures | COMPLETED | PHASE3 |
| NCT00735397 | Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures | COMPLETED | PHASE3 |